Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer

被引:29
作者
Tsolakidis, D. [1 ]
Amant, F. [1 ]
Van Gorp, T. [1 ]
Leunen, K. [1 ]
Neven, P. [1 ]
Vergote, I. [1 ]
机构
[1] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Obstet & Gynaecol, Div Gynaecol Oncol, B-3000 Louvain, European Union, Belgium
关键词
Primary debulking; Diaphragm; Coagulation; Stripping; Resection; Surgery; Ovarian cancer; Ovarian neoplasms; COMPLETE CYTOREDUCTIVE SURGERY; PRIMARY PERITONEAL CANCER; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; OPEN LAPAROSCOPY; FALLOPIAN-TUBE; CARCINOMA; RESECTION; SURVIVAL; IMPACT;
D O I
10.1016/j.ygyno.2009.07.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. The aim of this Study was to describe the role of diaphragmatic surgery in achieving optimal debulking in patients with advanced ovarian cancer and the assessment of the relative post-operative complications. Methods. Retrospective review was performed of medical records of 89 patients with epithelial ovarian cancer who underwent diaphragmatic surgery during their primary debulking surgery between September 1993 and December 2007. Four different approaches were performed: Coagulation (group I), stripping (group 2), combination stripping with coagulation (group 3) and diaphragm full thickness resection (group 4). Cytoreductive outcome, morbidity, overall Survival (OS) and disease-free Survival (DFS) were analysed. Results. Eight (8.9%) patients had FIGO stage IIIB, 64 (72%) stage IIIC and 17 (19.1%) stage IV disease. In 20 patients (22%) the diaphragmatic disease was coagulated, in 31 patients (35%) was only stripped, in 31 patients (35%) a combination of these techniques was applied and in 7 (8%) the disease was resected with the adjacent infiltrated part of the diaphragm muscle and the pleura above it. Debulking to no residual tumor was achieved in 90%, 86%. 86% and 100% for groups 1, 2, 3 and 4 respectively. Median DFS was 15,15,17 and overall Survival OS for groups 1, 2, and 3 was 40, 42, and 50 months respectively and was not yet reached for group 4. Minor and major complications were comparable among the groups. Pleural effusion was the most frequent associated complication and chest tube placement (17%) or thoracocentesis (12%) was necessary for the relief of respiratory distress. The perioperative mortality rate was 0%. The majority of cases were treated in the last five years Of our 15-year experience. Conclusions. Diaphragmatic surgery increases the rates of optimal primary debulking surgery and improves Survival with an acceptable and manageable morbidity rate. In patients with thick (>0.3 cm) OF large (>4 cm) lesions stripping the diaphragm or full thickness resection of the diaphragmatic muscle is preferred. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [21] Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery
    Paik, E. Sun
    Lee, Yoo-Young
    Shim, Minhee
    Choi, Hyun Jin
    Kim, Tae-Joong
    Choi, Chel Hun
    Lee, Jeong-Won
    Kim, Byoung-Gie
    Bae, Duk-Soo
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2016, 56 (06) : 639 - 647
  • [22] Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer
    Saitou, Motoaki
    Iida, Yasushi
    Komazaki, Hiromi
    Narui, Chikage
    Matsuno, Kanae
    Kawabata, Ayako
    Ueda, Kazu
    Tanabe, Hiroshi
    Takakura, Satoshi
    Isonishi, Seiji
    Sasaki, Hiroshi
    Okamoto, Aikou
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 291 (03) : 641 - 646
  • [23] Neoadjuvant chemotherapy followed by interval debulking surgery versus primary debulking surgery in the advanced epithelial ovarian cancer - a retrospective cohort study
    Maricic, Slobodan
    Mandic, Aljosa
    Dejanovic, Ninoslav
    Kladar, Nebojsa
    Popovic, Marina
    Ivkovic-Kapicl, Tatjana
    Gutic, Bojana
    Kokanov, Dunja
    VOJNOSANITETSKI PREGLED, 2021, 78 (11) : 1193 - 1199
  • [24] Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV
    Ataseven, Beyhan
    Grimm, Christoph
    Harter, Philipp
    Heitz, Florian
    Traut, Alexander
    Prader, Sonia
    du Bois, Andreas
    GYNECOLOGIC ONCOLOGY, 2016, 140 (02) : 215 - 220
  • [25] The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery
    Rutten, I. J. G.
    Ubachs, J.
    Kruitwagen, R. F. P. M.
    van Dijk, D. P. J.
    Beets-Tan, R. G. H.
    Massuger, L. F. A. G.
    Damink, S. W. M. Olde
    Van Gorp, T.
    EJSO, 2017, 43 (04): : 717 - 724
  • [26] Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Bian, Ce
    Yao, Kui
    Li, Li
    Yi, Tao
    Zhao, Xia
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (01) : 163 - 168
  • [27] Primary debulking surgery or neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Zheng, Hong
    Gao, Yu-Nong
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (04) : 304 - 309
  • [28] Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis
    Caruso, Giuseppe
    Palaia, Innocenza
    Bogani, Giorgio
    Tomao, Federica
    Perniola, Giorgia
    Panici, Pierluigi Benedetti
    Muzii, Ludovico
    Di Donato, Violante
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (05)
  • [29] Interval debulking surgery for advanced epithelial ovarian cancer
    Tangjitgamol, Siriwan
    Manusirivithaya, Sumonmal
    Laopaiboon, Malinee
    Lumbiganon, Pisake
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [30] Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
    Dabi, Yohann
    Huchon, Cyrille
    Ouldamer, Lobna
    Bendifallah, Sofiane
    Collinet, Pierre
    Bricou, Alexandre
    Darai, Emile
    Ballester, Marcos
    Lavoue, Vincent
    Haddad, Bassam
    Touboul, Cyril
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)